| Factor Information | |
|---|---|
| Data ID | 3153 |
| Factor | CVL duration over 3 days |
| Description | CVL= central venous lines |
| Biomarker | NA |
| Classification | A6 (clinical factor - other) |
| Association | |
|---|---|
| Application | risk assessment and prognosis |
| Objective | The objective of this study was to assess the efficacy of heparin-bonded catheters for preventing thrombosis in infants aged less than 1 year with congenital heart disease. |
| p Value | <0.001 |
| OR | 6.3 |
| Conclusion | Infants with congenital heart disease are at significant risk of both silent and clinically identified thrombosis. There seems to be no advantage in using heparin-bonded catheters in infants less than 1 year of age. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 655 |
| CHD Type | isolated CHD |
| CHD Subtype | VSD/ASD/TOF/TGA |
| Reference | |
|---|---|
| PMID | 19237438 |
| Year | 2008 |
| Title | Heparin-Bonded Central Venous Catheters Do Not Reduce Thrombosis in Infants With Congenital Heart Disease: A Blinded Randomized, Controlled Trial |
| Sample | ||
|---|---|---|
| Population | infants | |
| Source | patients' data | |
| Region | Toronto, Canada | |
| Method | logistic regression modeling | |
| Race | Canadian | |
| Disease History | N/A | |
| Treatment History | performed central venous lines | |
| Group | infants with CHD with CVL(Treatment) | N/A(Control) |
| Number | 87 | N/A |
| Age | infants younger than 1 year of age | N/A |
| Gender (Male: Female) | 46:41 | N/A |
| Marker Level | N/A | N/A |
